NASDAQ: SLDB       Solid Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
6.79   -0.07 (1.02%)  6.69 - 6.94  507,500


Avg Volume (4 weeks):1,090,063
4 Weeks Range:5.81 - 8.56
4 Weeks Price Volatility (%):
52 Weeks Range:1.93 - 8.56
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Solid Biosciences, lead product candidate the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2977  6172  443  90 

Top 10 Active Counters
 AMC 4.96-0.13 
 NOK 4.73-0.35 
 SNDL 0.56-0.045 
 BB 18.92-0.17 
 GE 11.29-0.74 
 GME 147.98+59.42 
 ATOS 2.61-0.75 
 AIKI 1.79+0.31 
 BIOL 1.50+0.36 
 CTRM 0.391-0.001